Found 0 matching trials
Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype PHASE3 The purpose of this study is to evaluate if a 12-week total regimen of tela...
Show More Location
Multiple Locations
Learn More & Join Trial
COVID-19 Immunologic Antiviral Therapy With Omalizumab PHASE2 To evaluate if omalizumab is effective in decreasing mortality in severe ho...
Show More Location
Niagara Health - St. Catharine's Sites
Learn More & Join Trial
A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B PHASE3 Current clinical practices has shown promising prospects of the therapy str...
Show More Location
Beijing Ditan Hospital, Capital Medical University
Learn More & Join Trial
Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia PHASE2 RATIONALE: Interferon alfa may interfere with the growth of cancer cells. I...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV PHASE4 The rapidly progression of the disease in HIV-HCV co-infected patients just...
Show More Location
Hospital General de Alicante
Learn More & Join Trial
Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver PHASE2 This early phase IIA trial studies how well celecoxib, recombinant interfer...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer PHASE2 RATIONALE: Chemoprevention therapy is the use of certain drugs to try to pr...
Show More Location
Hoag Memorial Hospital Presbyterian
Learn More & Join Trial
Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients PHASE1 The purpose of this study is to evaluate efficacy and safety of Radiofreque...
Show More Learn More & Join Trial
Phase III China GT 1b Interferon (IFN) Intolerant Prev Exclude Dual PHASE3 Patients with chronic hepatitis genotype 1b, who are intolerant or ineligib...
Show More Location
Local Institution
Learn More & Join Trial
Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Show More Location
Hoag Memorial Hospital Presbyterian
Learn More & Join Trial